
Kuros Biosciences re-appoints chief medical officer
pharmafile | March 8, 2016 | Appointment | Medical Communications |
Kuros Biosciences has announced the appointment of Dr Virginia Jamieson as chief medical officer and member of the executive board with immediate effect.
Dr Jamieson has spent over 25 years in the pharmaceutical industry, obtaining considerable experience in early and late-stage clinical development, product registration and medical affairs. Jamieson received her medical degree at Edinburgh University and obtained a postgraduate fellowship in anaesthesia from the Royal College of Surgeons in London.
In addition, she has a diploma from the Faculty of Pharmaceutical Medicine, where she has also been an appraiser for revalidation of physicians in the pharmaceutical industry. Dr Jamieson already worked for Kuros from 2005 to 2012 as medical director and then as chief medical officer, and is therefore very familiar with Kuros’ products, the company says.
Didier Cowling, chief executive of Kuros, comments: “We are delighted to have Virginia join us again. Her wealth of experience, both in the surgical field and pharmaceutical and medical industry, coupled with her deep knowledge of Kuros’ products, makes this a key appointment for us.”






